Redox-active metal(II) complexes of sterically hindered phenolic ligands: Antibacterial activity and reduction of cytochrome c
暂无分享,去创建一个
Y. Faletrov | V. Shkumatov | O. Shadyro | T. V. Koval'chuk | N. Loginova | A. A. Chernyavskaya | N. Osipovich | G. Polozov | A. Gres | I. Azarko | R. A. Zheldakova | Y. V. Faletrov
[1] O. Shadyro,et al. Synthesis, characterization, antifungal and anti-HIV activities of metal(II) complexes of 4,6-di-tert-butyl-3-[(2-hydroxyethyl)thio]benzene-1,2-diol. , 2008, European journal of medicinal chemistry.
[2] Julia L. Brumaghim,et al. Predicting how polyphenol antioxidants prevent DNA damage by binding to iron. , 2008, Inorganic chemistry.
[3] O. Shadyro,et al. Redox-active antifungal cobalt(II) and copper(II) complexes with sterically hindered o-aminophenol derivatives , 2008 .
[4] M. Fukuda,et al. Molecular mechanism of the redox-dependent interaction between NADH-dependent ferredoxin reductase and Rieske-type [2Fe-2S] ferredoxin. , 2007, Journal of molecular biology.
[5] M. Bureik,et al. ROS production by adrenodoxin does not cause apoptosis in fission yeast , 2007, Apoptosis.
[6] J. Mahy,et al. Synthesis, characterization and catalytic activity of halo-methyl-bis(salicylaldehyde)ethylenediamine cobalt(II) complexes , 2007 .
[7] B. Creaven,et al. Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2].8.8H(2)O and [Cu(4-Mecdoa)(phen)2].13H2O (phen=1,10-phenant , 2007, Journal of inorganic biochemistry.
[8] R. Bernhardt,et al. Cytochrome P450 systems--biological variations of electron transport chains. , 2007, Biochimica et biophysica acta.
[9] O. Shadyro,et al. Synthesis, characterization and antifungal activity of copper (II) complexes of sterically hindered o-diphenol derivatives , 2006 .
[10] O. Shadyro,et al. Synthesis and biological evaluation of copper (II) complexes of sterically hindered o-aminophenol derivatives as antimicrobial agents. , 2006, Bioorganic & medicinal chemistry letters.
[11] O. Shadyro,et al. Copper (II) complexes of sterically hindered o-diphenol derivatives: synthesis, characterization and microbiological studies , 2006 .
[12] A. Rosato,et al. Cytochrome c: occurrence and functions. , 2006, Chemical reviews.
[13] S. N. Azmi,et al. Kinetic spectrophotometric method for the determination of ramipril in pharmaceutical formulations , 2005, AAPS PharmSciTech.
[14] L. Ming,et al. Catechol oxidase-like oxidation chemistry of the 1-20 and 1-16 fragments of Alzheimer's disease-related beta-amyloid peptide: their structure-activity correlation and the fate of hydrogen peroxide. , 2005, The Journal of biological chemistry.
[15] A. Merchán,et al. Electron-transfer‐mediated binding of optically active cobalt(III) complexes to horse heart cytochrome c , 2005, Journal of The Royal Society Interface.
[16] M. Clynes,et al. Synthesis and X-ray crystal structure of [Ag(phendio)2]ClO4 (phendio = 1,10-phenanthroline-5,6-dione) and its effects on fungal and mammalian cells , 2004, Biometals.
[17] F. Muller,et al. Complex III Releases Superoxide to Both Sides of the Inner Mitochondrial Membrane* , 2004, Journal of Biological Chemistry.
[18] M. Devereux,et al. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to Amphotericin B and Miconazole , 2004, Biometals.
[19] D. Lopez-Colon,et al. Sonochemistry of antitumor quinones in argon-saturated aqueous solutions: enhanced ferricytochrome c reduction. , 2004, Ultrasonics sonochemistry.
[20] B. Ludwig,et al. Interaction of cytochrome c with cytochrome oxidase: two different docking scenarios. , 2004, Biochimica et biophysica acta.
[21] M. Sever,et al. Visible absorption spectra of metal-catecholate and metal-tironate complexes. , 2004, Dalton transactions.
[22] Robert O'Connor,et al. Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.
[23] A. Patterson,et al. Human NADPH-cytochrome p450 reductase overexpression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines. , 2003, Cancer research.
[24] R. Eldik,et al. Kinetics of the reduction of cytochrome c by [FeII(edta)(H2O)]2-: Outer-sphere vs. inner-sphere electron transfer mechanisms , 2003 .
[25] M. Devereux,et al. Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes , 2003, Biometals.
[26] N. Scrutton,et al. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. , 2003, The Biochemical journal.
[27] James B. Mitchell,et al. Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: Chemoprevention strategies with antioxidants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. S. Adam,et al. Synthesis and Physico‐Chemical Properties of Some Novel Amino Acid Azo Fe(II) Complexes , 2003 .
[29] A. Awad,et al. Synthesis and Characterization of Some Novel Amino Acid Schiff Base Fe(II) Complexes , 2003 .
[30] T. Porter,et al. Modification of the Nucleotide Cofactor-binding Site of Cytochrome P-450 Reductase to Enhance Turnover with NADH in Vivo * , 2002, The Journal of Biological Chemistry.
[31] M. Gross,et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. , 2002, Carcinogenesis.
[32] A. Whalen,et al. Valence tautomerism and metal-mediated catechol oxidation for complexes of copper prepared with 9,10-phenanthrenequinone. , 2001, Inorganic chemistry.
[33] C. Pierpont. Unique properties of transition metal quinone complexes of the MQ3 series , 2001 .
[34] C. Pierpont. Studies on charge distribution and valence tautomerism in transition metal complexes of catecholate and semiquinonate ligands , 2001 .
[35] F. Guengerich. Uncommon P450-catalyzed reactions. , 2001, Current drug metabolism.
[36] Gleb Bourenkov,et al. Adrenodoxin Reductase-Adrenodoxin Complex Structure Suggests Electron Transfer Path in Steroid Biosynthesis* , 2001, The Journal of Biological Chemistry.
[37] T. Montine,et al. Endogenous catechol thioethers may be pro-oxidant or antioxidant. , 1999, Free radical biology & medicine.
[38] D. Sem,et al. Mechanistic Studies on the Reductive Half-reaction of NADPH-Cytochrome P450 Oxidoreductase* , 1999, The Journal of Biological Chemistry.
[39] M. Zeghouf,et al. The flavoprotein component of the Escherichia coli sulfite reductase can act as a cytochrome P450c17 reductase. , 1998, Biochemical and biophysical research communications.
[40] A. Archakov,et al. The electron transfer reactions of NADPH: cytochrome P450 reductase with nonphysiological oxidants. , 1994, Archives of biochemistry and biophysics.
[41] K. Korzekwa,et al. Baculovirus-mediated expression and functional characterization of human NADPH-P450 oxidoreductase. , 1992, Archives of biochemistry and biophysics.
[42] Garner Rc. Assessment of carcinogen exposure in man , 1985 .
[43] C. Winterbourn. Superoxide dismutase-inhibitible reduction of cytochrome c by the alloxan radical. Implications for alloxan cytotoxicity. , 1982, The Biochemical journal.
[44] E. Margoliash,et al. Kinetics and mechanism of the reduction of ferricytochrome c by the superoxide anion. , 1982, The Journal of biological chemistry.
[45] M. Wilson,et al. Kinetic studies on the reduction of cytochrome c. Reaction with dihydroxy conjugated compounds (catechols and quinols). , 1982, The Biochemical journal.
[46] N. Bachur,et al. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[47] W. Koppenol,et al. The kinetics of the reduction of cytochrome c by the superoxide anion radical. , 1976, Biochimica et biophysica acta.
[48] W. Geary. The use of conductivity measurements in organic solvents for the characterisation of coordination compounds , 1971 .
[49] A. Davison. Kinetics of the copper-histidine catalysis of ferrocytochrome c oxidation. , 1968, The Journal of biological chemistry.
[50] H. Gray,et al. Electronic structures of hexacyanometalate complexes , 1968 .
[51] H. Nagasawa,et al. The oxidation of omicron-aminophenols by cytochrome c and cytochrome oxidase. II. Synthesis and identification of oxidation products. , 1959, The Journal of biological chemistry.
[52] Fritz Scholz,et al. Electro analytical methods: guide to experiments and applications. , 2010 .
[53] S. Djebbar,et al. Synthesis, characterization and antifungal activity of a series of manganese(II) and copper(II) complexes with ligands derived from reduced N,N'-O-phenylenebis(salicylideneimine). , 2008, Journal of inorganic biochemistry.
[54] M. Brechbiel,et al. Influence of ligand structure on Fe(II) spin-state and redox rate in cytotoxic tripodal chelators. , 2008, Journal of inorganic biochemistry.
[55] Agnieszka Bartoszek. Metabolic activation of adriamycin by NADPH-cytochrome P450 reductase; overview of its biological and biochemical effects. , 2002, Acta biochimica Polonica.
[56] A. Corma,et al. Quantitative EPR study of Mn(II)salen oxidation within zeolite Y , 2000 .
[57] A. Saha,et al. Low-spin manganese(II) and cobalt(III) complexes of N-aryl-2-pyridylazophenylamines: new tridentate N,N,N-donors derived from cobalt mediated aromatic ring amination of 2-(phenylazo)pyridine. Crystal structure of a manganese(II) complex , 2000 .
[58] Edward I. Solomon,et al. Inorganic electronic structure and spectroscopy , 1999 .
[59] J. K. Yandell. Kinetics of oxidation of reduced cytochrome c by aquacopper(II) and chlorocopper(II) complexes in the presence of oxygen , 1981 .
[60] P. V. Sengbusch,et al. Molekular- und Zellbiologie , 1979 .
[61] K. Nakamoto. Infrared and Raman Spectra of Inorganic and Coordination Compounds , 1978 .
[62] A. D. McLachlan,et al. Introduction to magnetic resonance : with applications to chemistry and chemical physics , 1967 .